Texas Oncology Gulf Coast — Houston, Texas

Texas Oncology Gulf Coast is a clinical research site located in Houston, Texas, United States 77024.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology Gulf Coast has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Breast Cancer, Uterine Serous Carcinoma.

Sponsors: Jazz Pharmaceuticals, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Gulf Coast?

Texas Oncology Gulf Coast has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Gulf Coast conducted?

Texas Oncology Gulf Coast has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Breast Cancer, Uterine Serous Carcinoma.

Is Texas Oncology Gulf Coast accredited by Crixeo Health?

Texas Oncology Gulf Coast has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Gulf Coast?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.